Intensive recirculating aquaculture systems are vulnerable to spikes of nitrite, which oxidizes hemoglobin to methemoglobin and compromises oxygen transport. Methylene blue (MB) is a classical antidote for methemoglobinemia, yet its use in fish has been limited to injections or immersion baths that are impractical for large-scale operations. This study assessed whether MB incorporated into a medicated feed could mitigate acute nitrite intoxication in Nile tilapia. Fish received either a control diet or 0.1% MB diet. After five days on the experimental diets, fish were exposed to nitrite for 48 h. Control fish experienced five deaths, whereas no mortality or behavioral distress was observed in MB-treated fish. Hematology indicated significantly lower circulating methemoglobin concentration in the MB group, while the control fish had higher hemoglobin concentration and erythrocyte counts, consistent with compensatory erythropoiesis. Gill histology revealed preserved lamellae with only mild changes in MB-fed fish, whereas control fish displayed lamellar aneurysm, edema, capillary congestion, fusion and epithelial hyperplasia. Therefore, oral MB administration appears to ameliorate the physiological consequences of acute nitrite exposure, offering a scalable intervention for emergency management of nitrite spikes. Future work should define dose–response relationships, evaluate post-exposure rescue, quantify gill lesions and assess MB residues in food fish.
Barbuio et al. (Sun,) studied this question.